Head-to-head · WeighScore
Fitness RX vs Zealthy
The verdict
Fitness RX takes it — 76.7/100 to 46.7/100.
Fitness RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fitness RX (fitnessrx.com) is a GLP-1 weight-loss program that bundles medication with fitness and nutrition coaching across a three-phase plan.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Fitness RX | Zealthy |
|---|---|---|
| WeighScore | 76.7/100 | 46.7/100 |
| Grade | C | C |
| Scorecard rank | #50 | #496 |
| Semaglutide | $119/mo (promotional rate, compounded) | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | $119/mo (promotional rate, compounded) | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | Coverage not published | 34 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #50 · C
Strengths
- $119/mo all-in including medication, 1:1 physician consults, and unlimited messaging ($100-off-for-life intro promo)
- Both compounded (injectable + sublingual semaglutide/tirzepatide) and brand GLP-1 (Wegovy, Zepbound)
- Integrated fitness and nutrition/behavioral coaching (linked to the BodyFX brand)
- Publishes Terms, Privacy, and data-privacy policies; links to LegitScript verification
Where it loses points
- Promo-driven landing page; compounding pharmacy and legal entity not named
- Tirzepatide and brand pricing may differ from the advertised $119/mo plan
- LegitScript status links to a CAPTCHA-gated checker — not independently confirmed here
- Exact drug and dose are shown only after the intake quiz
Graded #496 · C
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
Where it loses points
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.